The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds
Advanced Science · 2025-10 · 12 (37)
DOI: 10.1002/advs.202503098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.07.2025. Verfasst von Manyu Gong und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and Natural Medicine Chemistry, Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmace…. Hauptthemen laut MEDLINE: Wound Healing, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province of China, Heilongjiang Chunyan Talent Project.
Themen: Wundversorgung
Abstract (Originalsprache)
The approach to dealing with chronic wounds is still challenging in clinic. Multitarget drugs have the advantages of superior therapeutic effect and minimal adverse reactions. The aim of the present study is to develop a multitarget treatment strategy for skin wound healing. It is showed here that topical application of ZLY032, a dual free fatty acid receptor 1 (FFA1)/peroxisome proliferator‐activated receptor (PPARδ) agonist, accelerates the healing of full‐thickness skin wounds in both normal mice and rabbits, even in the diabetic mice and methicillin‐resistant Staphylococcus aureus (MRSA) infected mice. At the eukaryotic cell level, ZLY032 shows the ability to accelerate angiogenesis and inhibit inflammation via targeting PPARδ and FFA1. At the prokaryotic cell level, ZLY032 exhibits antibacterial activity against Staphylococcus aureus and MRSA via targeting argininosuccinate lyase (ASAL, argH ). At the application level, ZLY032‐loaded microneedles demonstrate a therapeutic effect on wound healing in rabbits with an improved dosing frequency. In this work, ZLY032 application is verified as a potential multitarget strategy for wound healing with good safety and efficacy. Furthermore, the discovery of the antimicrobial target of ZLY032 provides a theoretical basis for the development of novel antibiotics against drug‐resistant strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry and Natural Medicine Chemistry, Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Mi…
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, P. R. China.
- The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150081, China.
- Department of Pharmaceutics, School of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
- Genomics Research Center, Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, State-Province Key Laboratory of Biomedicine-Pharmaceutics of China, College of Pharmacy, Harbin Medical Universi…
ORCID-Profile: Lei Jiao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province of China
- Heilongjiang Chunyan Talent Project
Zitieren
APA
Gong, M., Du, Z., Gong, T., Wang, Y., Yin, C., Sun, B., Liu, Z., Chen, L., Liao, Z., Wang, W., Zhao, T., Wang, Y., Dong, Y., Wang, K., Ma, M., Li, W., Li, J., Li, H., Lin, C., …, & Jiao, L. (2025). The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds. Advanced Science, 12(37). https://doi.org/10.1002/advs.202503098
Vancouver
Gong M, Du Z, Gong T, Wang Y, Yin C, Sun B, et al. The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds. Advanced Science. 2025;12(37). doi:10.1002/advs.202503098
BibTeX
@article{Gong2025,
author = {Gong, Manyu and Du, Zhiyuan and Gong, Tiantian and Wang, Yu and Yin, Chenchen and Sun, Bosi and Liu, Zijia and Chen, Lianru and Liao, Zibin and Wang, Wenxin and Zhao, Tianjiao and Wang, Yifei and Dong, Ying and Wang, Kexin and Ma, Mengru and Li, Weijun and Li, Jiacheng and Li, Haodong and Lin, Congcong and Zhang, Ying and Liu, Yu and Liu, Xin and Ban, Tao and Bao, Hongxia and Zhang, Ying and Zhang, Yang and Li, Zheng and Jiao, Lei},
title = {The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {37},
doi = {10.1002/advs.202503098}
}
EUVIMED